Skip to main content

Appraisals in progress

Patients, carers and patient organisations - please see our New medicines needing your views page for answers to some questions you might have about making a submission.

Clinical experts - please see our Clinical expert opinion for medicine appraisals page for background information.

We'd like to receive your submission before the stated deadline (so we can prepare the meeting papers). But we'll still try to include any that arrive late.

Medicine name: dolutegravir (Tivicay®)

Reference number: 4611

Indication: In combination with other anti-retroviral medicinal products for the treatment of human immunodeficiency virus (HIV) infected adults, adolescents and children of at least 4 weeks of age or older and weighing at least 3 kg.

Patient and carer submission: Download form or submit online

Patient organisation submission: Download form or submit online

Clinical experts submission: Download form

Submission deadline: 28/04/2021

AWMSG meeting date: 14/09/2021

Medicine name: etravirine (Intelence®)

Reference number: 4506

Indication: In combination with a boosted protease inhibitor and other antiretroviral medicinal products, for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in antiretroviral treatment-experienced paediatric patients from 2 to <6 years of age.

Patient and carer submission: Download form or submit online

Patient organisation submission: Download form or submit online

Clinical experts submission: Download form

Submission deadline: 01/07/2021

AWMSG meeting date: 14/09/2021

Medicine name: everolimus (Votubia®)

Reference number: 2142

Indication: Adjunctive treatment of patients aged 2 years and older whose refractory partial-onset seizures, with or without secondary generalisation, are associated with tuberous sclerosis complex (TSC).

Patient and carer submission: Download form or submit online

Patient organisation submission: Download form or submit online

Clinical experts submission: Download form

Submission deadline: 23/06/2021

AWMSG meeting date: 14/09/2021

Medicine name: nitisinone (Orfadin®)

Reference number: 2322

Indication: Treatment of adult patients with alkaptonuria.

Patient and carer submission: Download form or submit online

Patient organisation submission: Download form or submit online

Clinical experts submission: Download form

Submission deadline: 23/06/2021

AWMSG meeting date: 14/09/2021

Medicine name: amikacin liposomal (Arikayce®)

Reference number: 2140

Indication: Treatment of non-tuberculous mycobacterial (NTM) lung infections caused by Mycobacterium avium Complex (MAC) in adults with limited treatment options who do not have cystic fibrosis.

Patient and carer submission: Download form or submit online

Patient organisation submission: Download form or submit online

Clinical experts submission: Download form

Submission deadline: 11/06/2021

AWMSG meeting date: 14/09/2021

Medicine name: buprenorphine (Sixmo®)

Reference number: 2462

Indication: Substitution treatment for opioid dependence in clinically stable adult patients who require no more than 8 mg/day of sublingual buprenorphine, within a framework of medical, social and psychological treatment.

Patient and carer submission: Download form or submit online

Patient organisation submission: Download form or submit online

Clinical experts submission: Download form

Submission deadline: 20/09/2021

AWMSG meeting date: TBC

Medicine name: cannabidiol (Epidyolex®)

Reference number: 3201

Indication: Adjunctive therapy of seizures associated with tuberous sclerosis complex (TSC) for patients 2 years of age and older.

Patient and carer submission: Download form or submit online

Patient organisation submission: Download form or submit online

Clinical experts submission: Download form

Submission deadline: 21/09/2021

AWMSG meeting date: 08/12/2021

Medicine name: dabigatran etexilate (Pradaxa®)

Reference number: 2293

Indication: Treatment of VTE and prevention of recurrent VTE in paediatric patients from 8 years to less than 18 years of age.

Patient and carer submission: Download form or submit online

Patient organisation submission: Download form or submit online

Clinical experts submission: Download form

Submission deadline: TBC

AWMSG meeting date: TBC

Medicine name: clostridium botulinum type A toxin-haemagglutinin complex (Dysport®)

Reference number: 2626

Indication: Symptomatic treatment of focal spasticity of upper limbs in paediatric cerebral palsy patients, two years of age or older.

Patient and carer submission: Download form or submit online

Patient organisation submission: Download form or submit online

Clinical experts submission: Download form

Submission deadline: TBC

AWMSG meeting date: TBC